Inicio>>Signaling Pathways>> Ubiquitination/ Proteasome>> Autophagy>>Arctigenin

Arctigenin

Catalog No.GN10063

Arctigenin, un compuesto natural de lignano, ha demostrado actividades anticancerígenas en el cáncer. Arctigenina exhibe potentes actividades antioxidantes, antiinflamatorias y antivirales (virus de la influenza A).

Products are for research use only. Not for human use. We do not sell to patients.

Arctigenin Chemical Structure

Cas No.: 7770-78-7

Tamaño Precio Disponibilidad Cantidad
10mM (in 1mL DMSO)
34,00 $
Disponible
20mg
70,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com


Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description of Arctigenin

Arctigenin, un compuesto natural de lignano, ha demostrado actividades anticancerígenas en el cáncer. Arctigenina exhibe potentes actividades antioxidantes, antiinflamatorias y antivirales (virus de la influenza A)[3,4].

Arctigenina (40 µM; 48h) inhibió el crecimiento de células U87MG y T98G, indujo la detención del ciclo celular en la fase G0/G1 y desencadenó la apoptosis celular en células de glioma [1]. Arctigenina (10, 20, 40, 80 y 100 μmol/L; 48h) posee actividad antitumoral en células T24 de cáncer de vejiga. A nivel molecular, la arctigenina fue capaz de reducir la expresión de ciclinas D1 y fosfo-ERK1/2, pero inducir niveles de fosfo-p38 [4]. Arctigenina (0, 1.56, 12.5, 100 μM; 24h) induce la apoptosis en células de HCC a través de vías apoptóticas dependientes de mitocondrias y Fas/FasL [5].

Arctigenina (25 mg/kg; ip; dos veces al día) durante 23 días aumentó la fosforilación de AKT estimulada por insulina en el músculo gastrocnemio y el hígado, pero no en la grasa perirrenal [2]. Arctigenina (50 mg/kg/día; ip) durante 4 días confiere protección contra el daño inflamatorio y oxidativo inducido por LPS en el pulmón [6].

References:
[1]. Maimaitili A, Shu Z, Cheng X, Kaheerman K, Sikandeer A, Li W. Arctigenin, a natural lignan compound, induces G0/G1 cell cycle arrest and apoptosis in human glioma cells. Oncol Lett. 2017 Feb;13(2):1007-1013
[2]. Huang SL, Yu RT, Gong J, Feng Y, Dai YL, Hu F, Hu YH, Tao YD, Leng Y. Arctigenin, a natural compound, activates AMP-activated protein kinase via inhibition of mitochondria complex I and ameliorates metabolic disorders in ob/ob mice. Diabetologia. 2012 May;55(5):1469-81.
[3]. Hayashi K, Narutaki K, Nagaoka Y, Hayashi T, Uesato S. Therapeutic effect of arctiin and arctigenin in immunocompetent and immunocompromised mice infected with influenza A virus. Biol Pharm Bull. 2010;33(7):1199-205.
[4]. Yang S, Ma J, Xiao J, Lv X, Li X, Yang H, Liu Y, Feng S, Zhang Y. Arctigenin anti-tumor activity in bladder cancer T24 cell line through induction of cell-cycle arrest and apoptosis. Anat Rec (Hoboken). 2012 Aug;295(8):1260-6.
[5]. Lu Z, Cao S, Zhou H, Hua L, Zhang S, Cao J. Mechanism of Arctigenin-Induced Specific Cytotoxicity against Human Hepatocellular Carcinoma Cell Lines: Hep G2 and SMMC7721. PLoS One. 2015 May 1;10(5):e0125727.
[6]. Zhang WZ, Jiang ZK, He BX, Liu XB. Arctigenin Protects against Lipopolysaccharide-Induced Pulmonary Oxidative Stress and Inflammation in a Mouse Model via Suppression of MAPK, HO-1, and iNOS Signaling. Inflammation. 2015 Aug;38(4):1406-14.

Protocol of Arctigenin

Experimentos celulares [1]:

Líneas celulares

Líneas celulares de glioma humano U87MG y T98G

Método de preparación

Las líneas celulares de glioma humano U87MG y T98G fueron tratadas con arctigenina (1-40 μM) durante 48 horas.

Condiciones de reacción

Arctigenina (1-40 μM); 48 h

Áreas de aplicación

La arctigenina inhibió el crecimiento de las células U87MG y T98G de manera dependiente de la dosis.
Experimentos con animales [2]:

Modelos animales

Modelo de ratones hembra ob/ob

Método de preparación

Se administró arctigenina a ratones hembra ob/ob (25 mg/kg; ip; dos veces al día) durante 22 días.

Forma de dosificación

Arctigenina (200 mg/kg cada 2 días); 23 días; ip.

Áreas de aplicación

La arctigenina (25 mg/kg; ip; dos veces al día) aumentó la fosforilación de AKT estimulada por insulina en el músculo gastrocnemio y el hígado, pero no en la grasa perirrenal.

Referencias:

[1]. Maimaitili A, Shu Z, Cheng X, Kaheerman K, Sikandeer A, Li W. Arctigenin, a natural lignan compound, induces G0/G1 cell cycle arrest and apoptosis in human glioma cells. Oncol Lett. 2017 Feb;13(2):1007-1013.

[2]. Huang SL, Yu RT, Gong J, Feng Y, Dai YL, Hu F, Hu YH, Tao YD, Leng Y. Arctigenin, a natural compound, activates AMP-activated protein kinase via inhibition of mitochondria complex I and ameliorates metabolic disorders in ob/ob mice. Diabetologia. 2012 May;55(5):1469-81.

Chemical Properties of Arctigenin

Cas No. 7770-78-7 SDF
Chemical Name (3R,4R)-4-[(3,4-dimethoxyphenyl)methyl]-3-[(4-hydroxy-3-methoxyphenyl)methyl]oxolan-2-one
Canonical SMILES COC1=C(C=C(C=C1)CC2COC(=O)C2CC3=CC(=C(C=C3)O)OC)OC
Formula C21H24O6 M.Wt 372.41
Solubility ≥ 17.2mg/mL in DMSO Storage Desiccate at -20°C
General tips Please select the appropriate solvent to prepare the stock solution according to the solubility of the product in different solvents; once the solution is prepared, please store it in separate packages to avoid product failure caused by repeated freezing and thawing.Storage method and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored at -20°C, please use it within 1 month.
To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time.
Shipping Condition Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request.

Complete Stock Solution Preparation Table of Arctigenin

Prepare stock solution
1 mg 5 mg 10 mg
1 mM 2.6852 mL 13.4261 mL 26.8521 mL
5 mM 0.537 mL 2.6852 mL 5.3704 mL
10 mM 0.2685 mL 1.3426 mL 2.6852 mL
  • Molarity Calculator

  • Dilution Calculator

  • Molecular Weight Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
**When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and MSDS / CoA (available online).

Calculate

In vivo Formulation Calculator (Clear solution) of Arctigenin

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.

Product Documents

Quality Control & SDS

View current batch:

Reseñas

Review for Arctigenin

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Arctigenin

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.